{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:59:55Z","timestamp":1648796395843},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s11910-004-0085-6","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T16:13:25Z","timestamp":1180109605000},"page":"384-390","source":"Crossref","is-referenced-by-count":2,"title":["Neuro-ophthalmology of von Hippel-Lindau"],"prefix":"10.1007","volume":"4","author":[{"given":"Eric W.","family":"Fitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,10,1]]},"reference":[{"key":"85_CR1","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0161-6420(01)00758-8","volume":"108","author":"AD Singh","year":"2001","unstructured":"Singh AD, Nouri M, Shields CL, Shields JA: Retinal capillary hemangioma: A comparison of sporatic cases and cases associated with von Hippel-Lindau disease. Ophthalmology 2001, 108:1907\u20131911.","journal-title":"Ophthalmology"},{"key":"85_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1365-2796.1998.00338.x","volume":"243","author":"D Wittebol-Post","year":"1998","unstructured":"Wittebol-Post D, Hes FJ, Lips CJ: The eye in von Hippel-Lindau disease. Long term follow up of screening and treatment. Recommendations. J Int Med 1998, 243:555\u2013561.","journal-title":"J Int Med"},{"key":"85_CR3","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, et al.: Von Hippel-Lindau disease. Lancet 2003, 361:2059\u20132067.","journal-title":"Lancet"},{"key":"85_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/archopht.119.8.1226","volume":"119","author":"AD Singh","year":"2001","unstructured":"Singh AD, Shields JA, Shields CL: Solitary capillary hemangioma: hereditary (von Hippel-Lindau desease) or nonhereditary? Arch Ophthalmol 2001, 119:232\u2013234.","journal-title":"Arch Ophthalmol"},{"key":"85_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, et al.: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260:1317\u20131320.","journal-title":"Science"},{"key":"85_CR6","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/archopht.119.11.1659","volume":"119","author":"RC Allen","year":"2001","unstructured":"Allen RC, Webster AR, Sui F, et al.: Molecular characterization and ophthalmic investigation of a large family with Type 2A von-Hippel Lindau Dsease. Arch Ophthalmol 2001, 119:1659\u20131665.","journal-title":"Arch Ophthalmol"},{"key":"85_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.10807","volume":"55","author":"SD Wait","year":"2004","unstructured":"Wait SD, Vortmeyer AO, Lonser RR, et al.: Somatic mutations in VHL germline deletion kindred correlate with mild phenotype. Ann Neurol 2004, 55:236\u2013240. Five tumors from three patients with the same germline deletion were analyzed and found to have five different somatic mutations in five different locations.","journal-title":"Ann Neurol"},{"key":"85_CR8","first-page":"7051","volume":"63","author":"AO Vortmeyer","year":"2003","unstructured":"Vortmeyer AO, Frank S, Jeong SY, et al.: Developmental arrest of angioblastic lineage initiates tumorgenesis in von Hippel-Lindau Disease. Cancer Res 2003, 63:7051\u20137055.","journal-title":"Cancer Res"},{"key":"85_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1076\/opge.23.1.21.2201","volume":"23","author":"AD Singh","year":"2002","unstructured":"Singh AD, Ahmad NN, Shields JA, Shields CL: Solitary Capillary Hemangioma: Lack of genetic evidence for von Hippel-Lindau disease. Ophthal Genet 2002, 23:21\u201327.","journal-title":"Ophthal Genet"},{"key":"85_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/humu.10309","volume":"23","author":"S Ruiz-Llorente","year":"2004","unstructured":"Ruiz-Llorente S, Bravo J, Cebrian A, et al.: Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations. Hum Mutat 2004, 23:160\u2013169. The paper includes a good review of the current status of and indications for genetic testing in VHL.","journal-title":"Hum Mutat"},{"key":"85_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, et al.: Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990, 77:1151\u20131163.","journal-title":"Q J Med"},{"key":"85_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","volume":"46","author":"AD Singh","year":"2001","unstructured":"Singh AD, Shields JA, Shields CL: von Hippel-Lindau disease. Survey Ophthalmol 2001, 46:117\u2013142.","journal-title":"Survey Ophthalmol"},{"key":"85_CR13","first-page":"1909","volume":"41","author":"M Niemela","year":"2000","unstructured":"Niemela M, Lemeta S, Sainio M, et al.: Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. Invest Ophthalmol Vis Sci 2000, 41:1909\u20131915.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"85_CR14","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","volume":"109","author":"AD Singh","year":"2002","unstructured":"Singh AD, Nouri M, Shields CL, et al.: Treatment of retinal capillary hemangioma. Ophthalmology 2002, 109:1799\u20131806.","journal-title":"Ophthalmology"},{"key":"85_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","volume":"98","author":"JE Wanebo","year":"2003","unstructured":"Wanebo JE, Lonser RR, Glenn GM, Oldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003, 98:82\u201394.","journal-title":"J Neurosurg"},{"key":"85_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archopht.117.3.371","volume":"117","author":"AR Webster","year":"1999","unstructured":"Webster AR, Maher ER, Moore AT: Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999, 117:371\u2013378.","journal-title":"Arch Ophthalmol"},{"key":"85_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/00006982-200310000-00011","volume":"23","author":"B Raju","year":"2003","unstructured":"Raju B, Maji AB, Jalali S: von Hippel angioma in South Indian subjects\u2014a clinical study. Retina 2003, 23:670\u2013674.","journal-title":"Retina"},{"key":"85_CR18","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/S0161-6420(00)00422-X","volume":"107","author":"CM McCabe","year":"2000","unstructured":"McCabe CM, Flynn HW, Shields CL, et al.: Juxtapapillary capillary hemangiomas: Clinical features and visual acuity outcomes. Ophthalmology 2000, 107:2240\u20132249.","journal-title":"Ophthalmology"},{"key":"85_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","volume":"109","author":"LP Aiello","year":"2002","unstructured":"Aiello LP, George DJ, Cahill MT, et al.: Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416. Ophthalmology 2002, 109:1745\u20131751. A case report of visual improvement with anti-VEGF treatment.","journal-title":"Ophthalmology"},{"key":"85_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMp030061","volume":"349","author":"DJ George","year":"2003","unstructured":"George DJ, Daelin WG: The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer. N Engl J Med 2003, 349:419\u2013421. This is a brief, up-to-date review of the functions of pVHL and its relationship to angiogenesis and neoplasia.","journal-title":"N Engl J Med"},{"key":"85_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE, Kealin WG, Pavletich NP: Structure of the VHLElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 1999, 284:455\u2013461.","journal-title":"Science"},{"key":"85_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0959-437X(00)00152-0","volume":"11","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kaelin WG: The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 2001, 11:27\u201334.","journal-title":"Curr Opin Genet Dev"},{"key":"85_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00417-003-0631-y","volume":"241","author":"Y Miyagawa","year":"2003","unstructured":"Miyagawa Y, Nakazawa M, Noda Y, et al.: von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair inframe insertion mutation in the VHL gene. Graefe\u2019s Arch Clin Exp Ophthalmol 2003, 241:241\u2013244.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"85_CR24","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1210\/jc.2002-020651","volume":"87","author":"G Weirich","year":"2002","unstructured":"Weirich G, Klein B, Wohl T, et al.: VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V. J Clin Endocrinol Metab 2002, 87:5241\u20135246.","journal-title":"J Clin Endocrinol Metab"},{"key":"85_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ncb899","volume":"5","author":"A Hergovich","year":"2003","unstructured":"Hergovich A, Lisztwan J, Barry R, et al.: Regulation of microtubule stability by the von Hippel-Lindau tumor suppressor protein pVHL. Nature Cell Biol 2003, 5:64\u201370.","journal-title":"Nature Cell Biol"},{"key":"85_CR26","first-page":"2929","volume":"62","author":"MA Esteban-Barragan","year":"2002","unstructured":"Esteban-Barragan MA, Avila P, Alvarez-Tejado M, et al.: Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions. Cancer Res 2002, 62:2929\u20132936.","journal-title":"Cancer Res"},{"key":"85_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/sj.onc.1205121","volume":"21","author":"AO Vortmeyer","year":"2002","unstructured":"Vortmeyer AO, Huang SC, Pack SD, et al.: Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion. Oncogene 2002, 21:1167\u20131170.","journal-title":"Oncogene"},{"key":"85_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","volume":"10","author":"SC Clifford","year":"2001","unstructured":"Clifford SC, Cockman ME, Smallwood AC, et al.: Contrasting effects on HIF-1a regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 2001, 10:1029\u20131038.","journal-title":"Hum Mol Genet"},{"key":"85_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","volume":"10","author":"MA Hoffmann","year":"2001","unstructured":"Hoffmann MA, Ohh M, Yang H, et al.: von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 2001, 10:1019\u20131027.","journal-title":"Hum Mol Genet"},{"key":"85_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ophtha.2003.04.003","volume":"111","author":"D Raja","year":"2004","unstructured":"Raja D, Benz MS, Murray TG, et al.: Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease. Ophthalmology 2004, 111:250\u2013253.","journal-title":"Ophthalmology"},{"key":"85_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00006982-200204000-00019","volume":"22","author":"H Rodriguez-Coleman","year":"2002","unstructured":"Rodriguez-Coleman H, Spaide RF, Yannuzzi LA: Treatment of angiomatous lesions of the retina with photodynamic therapy. Retina 2002, 22:228\u2013232.","journal-title":"Retina"},{"key":"85_CR32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1023\/A:1008213320642","volume":"8","author":"M Los","year":"1997","unstructured":"Los M, Aarsman CJ, Terpstra L, et al.: Elevated levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol 1997, 8:1015\u20131022.","journal-title":"Ann Oncol"},{"key":"85_CR33","first-page":"4848","volume":"6","author":"DB Mendel","year":"2000","unstructured":"Mendel DB, Schreck RE, West DC, et al.: The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Clin Cancer Res 2000, 6:4848\u20134852.","journal-title":"Clin Cancer Res"},{"key":"85_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","volume":"135","author":"JF Girmens","year":"2003","unstructured":"Girmens JF, Erginay A, Massin P, et al.: Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than hemangioblatomas. Am J Ophthalmol 2003, 135:194\u2013196. This is a single case report showing visual improvement in one patient with anti-VEGF treatment.","journal-title":"Am J Ophthalmol"},{"key":"85_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa021491","volume":"349","author":"JC Yang","year":"2003","unstructured":"Yang JC, Haworth L, Sherry RM, et al.: A randomized trail of bevacizumab, an anti-vascular endothelial growth factor, for metastatic renal cancer. N Engl J Med 2003, 349:427\u2013434. This paper presents a double-blind, placebo-controlled, phase II trial of anti-VEGF antibody in patients with metastatic clear cell renal carcinoma. Treatment was shown to cause a dose-dependent prolongation in time of progression of disease, but did not cause much objective tumor response.","journal-title":"N Engl J Med"},{"key":"85_CR36","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1517\/13543784.12.8.1403","volume":"12","author":"RM Bukowski","year":"2003","unstructured":"Bukowski RM: AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma. Expert Opin Invest Drugs 2003, 12:1403\u20131411. This paper reviewed the mechanism of action of AE-951, an isolate of shark cartilage with four different mechanisms of action germane to therapy of VHL-associated tumors.","journal-title":"Expert Opin Invest Drugs"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-004-0085-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0085-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0085-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T23:43:18Z","timestamp":1566171798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-004-0085-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s11910-004-0085-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}